What is Genetica?
Genetica operates at the intersection of artificial intelligence and the cannabis industry, providing a sophisticated suite of tools designed to optimize market navigation for both consumers and commercial entities. Its flagship offering, the Flora AI Product Suite, serves as a critical technological layer that enhances operational efficiency and decision-making capabilities. By integrating machine learning with industry-specific data, Genetica empowers stakeholders to navigate the complexities of the evolving cannabis market with precision and scalability. The company's focus on high-impact AI solutions positions it as a key infrastructure provider in a rapidly maturing sector.
How much funding has Genetica raised?
Genetica has raised a total of $2.5M across 2 funding rounds:
Angel/Seed
$500K
Other Financing Round
$2M
Angel/Seed (2023): $500K with participation from Michael Heller, Show Me Organics, Ensemble Investments, Mitchell Harounian, and Hara Supply
Other Financing Round (2023): $2M led by JAM Fund
Key Investors in Genetica
Ensemble Investments
Ensemble Corporate specializes in impactful investments and the development of quality real estate across sectors including life science and office spaces, managing over $2.1 billion in assets.
Hara Supply
Hara Supply is a leading manufacturer of pre-rolled cones and custom packaging, serving as a critical supply chain partner for cannabis processors and dispensaries globally.
JAM Fund
JAM Fund is a charitable organization that supports children with life-threatening illnesses through community-driven fundraising and philanthropic initiatives.
What's next for Genetica?
With the successful closure of this latest financing round, Genetica is poised to enter a new phase of enterprise-level expansion. The strategic allocation of this capital will likely focus on the further development of the Flora AI Product Suite, enhancing its predictive capabilities and expanding its reach into new geographic markets. As the cannabis industry continues to face regulatory and operational hurdles, Genetica's role as a technological enabler becomes increasingly vital. The company is expected to prioritize partnerships with large-scale processors and dispensaries, leveraging its recent investment to solidify its competitive moat and drive long-term value for its stakeholders.
See full Genetica company page
